ISPOR Europe 2024 Home
Toggle navigation
About
News Center
Award Winners
Program
Program
Student Program
Learning Formats
Plenary Sessions
Posters
Program Committee
Digital Conference Pass
Exhibits & Sponsorship
Sponsor List
Media Partners
Exhibitor Directory
Photo Gallery
ISPOR
Europe 2024
17 - 20 November
Home
Events
Past Conferences
ISPOR Europe 2024
Program
Plenary Sessions
Session
Cost-Effectiveness Analysis of Acalabrutinib for Patients With Relapse and Refractory Chronic Lymphocytic Leukemia (R/R CLL)
Nov 18, 2024, 10:30 AM
«
2651
2652
2653
2654
2655
(current)
2656
2657
2658
2659
2660
»